Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled TrialVedang Murthy, Umesh Mahantshetty, Santosh Menon et al.|Journal of Clinical Oncology|2021Cited by 338
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancerVijay Patil, Manish Pandey, Vanita Noronha et al.|Cancer|2019Cited by 133
68Ga-prostate-specific membrane antigen PETCT-based response to androgen deprivation therapy in patients with prostate cancerPriyamvada Gupta, Venkatesh Rangarajan, Vedang Murthy et al.|Nuclear Medicine Communications|2019Cited by 5
Pilot study comparing dominant intraprostatic lesion volume using Ga-68 prostate-specific membrane antigen PET-computed tomography and multiparametric MRIAjay Sasidharan, Palak Popat, Vedang Murthy et al.|Nuclear Medicine Communications|2020Cited by 4